KIRIL DOMUSCHIEV AND GEORGI DOMUSCHIEF

Lobbying client · filed 2025 to 2026

Owners of Huvepharma, one of the largest animal pharmaceutical companies, globally. Number

$300,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (60998), not by name.

Firms hired 1

WASHINGTON GLOBAL ADVISORS LLC $300,000 6 filings

Reported by year 2 years

2026 $75,000 2 filings
2025 $225,000 4 filings

Issues lobbied 1

Animals 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

Commerce, Dept of (DOC) 5
State, Dept of (DOS) 1

Recent filings 6 total

Q2

WASHINGTON GLOBAL ADVISORS LLC

2nd Quarter (Apr 1 - June 30) 2026 · posted Aug 14, 2026

View → Q1

WASHINGTON GLOBAL ADVISORS LLC

1st Quarter (Jan 1 - Mar 31) 2026 · $75,000 income · posted Jun 1, 2026

View → Q4

WASHINGTON GLOBAL ADVISORS LLC

4th Quarter (Oct 1 - Dec 31) 2025 · $75,000 income · posted Feb 8, 2026

View → Q3

WASHINGTON GLOBAL ADVISORS LLC

3rd Quarter (July 1 - Sep 30) 2025 · $75,000 income · posted Oct 31, 2025

View → Q2

WASHINGTON GLOBAL ADVISORS LLC

2nd Quarter (Apr 1 - June 30) 2025 · $75,000 income · posted Aug 10, 2025

View → Q1Y

WASHINGTON GLOBAL ADVISORS LLC

1st Quarter (Jan 1 - Mar 31) 2025 · posted May 7, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.